Correlation Between Dr Reddys and Disc Medicine

Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Disc Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Disc Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dr Reddys Laboratories and Disc Medicine, you can compare the effects of market volatilities on Dr Reddys and Disc Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Disc Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Disc Medicine.

Diversification Opportunities for Dr Reddys and Disc Medicine

-0.71

Correlation Coefficient

Dr Reddys  Disc Medicine

Pay attention - limited upside

The 3 months correlation between RDY and Disc is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Disc Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Disc Medicine and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Disc Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Disc Medicine has no effect on the direction of Dr Reddys i.e., Dr Reddys and Disc Medicine go up and down completely randomly.

Pair Corralation between Dr Reddys and Disc Medicine

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to under-perform the Disc Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Dr Reddys Laboratories is 3.31 times less risky than Disc Medicine. The stock trades about -0.17 of its potential returns per unit of risk. The Disc Medicine is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  4,961  in Disc Medicine on August 31, 2024 and sell it today you would earn a total of  1,494  from holding Disc Medicine or generate 30.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dr Reddys Laboratories  vs.  Disc Medicine

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Disc Medicine

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Disc Medicine are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Disc Medicine displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dr Reddys and Disc Medicine

The main advantage of trading using opposite Dr Reddys and Disc Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Disc Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will offset losses from the drop in Disc Medicine's long position.

The idea behind Dr Reddys Laboratories and Disc Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.